Continuing education: The emergence of thalidomide in treating advanced renal cell carcinoma.
To review standard and investigational treatments in advanced renal cell carcinoma, with a focus on thalidomide. Published articles, conference proceedings, treatment guidelines, and textbooks. The prognosis for advanced renal cell carcinoma when treated with standard regimens is poor; therefore, new treatments are needed. Treatment with thalidomide, alone and in combination with other therapies, may improve survival for patients with advanced renal cell carcinoma. Proactive management of adverse effects associated with thalidomide, alone and in combination, may increase patient tolerance and compliance.